AVITA Medical (RCEL) Share-based Compensation (2018 - 2025)

AVITA Medical's Share-based Compensation history runs 8 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• Quarterly Share-based Compensation fell 50.93% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.5 million (down 29.47% YoY) and the FY2025 annual result came in at $9.5 million, down 29.47% from the prior year.
• Share-based Compensation was $1.4 million for Q4 2025 at AVITA Medical, down from $2.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.6 million in Q3 2021 and bottomed at $1.1 million in Q2 2023.
• A 5-year average of $2.6 million and a median of $2.7 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 68.68% — and 2024, when it surged 252.32%.
• AVITA Medical's Share-based Compensation stood at $4.6 million in 2021, then sank by 45.39% to $2.5 million in 2022, then fell by 13.3% to $2.2 million in 2023, then grew by 28.88% to $2.8 million in 2024, then slumped by 50.93% to $1.4 million in 2025.
• Business Quant data shows RCEL's Share-based Compensation at $1.4 million in Q4 2025, $2.8 million in Q3 2025, and $2.7 million in Q2 2025.